TSHR Knockout MOLP-8 Cell Line

The choice depends on whether you are studying TSHR's role in thyroid signaling, modeling thyroid disease, or investigating its non-canonical expression in multiple myeloma. The Knockout line is the standard tool for these questions — particularly for studying TSHR signaling consequences in the MOLP-8 multiple myeloma context where TSHR has been reported with non-thyroid functions. Overexpression is useful for studying disease-associated activating mutations or for ligand-binding studies. Important context: TSHR is a major GPCR drug target, and MOLP-8 is a multiple myeloma cell line — the choice of MOLP-8 as the host suggests focus on TSHR's non-thyroid functions in hematological malignancies rather than classical thyroid biology. Rescue with wild-type, constitutively active (e.g., D633Y), or inactivating mutant TSHR is particularly informative for distinguishing constitutive from ligand-induced functions.

Primary applications: • GPCR signaling assays: cAMP measurement following TSH or thyrostimulin stimulation to assess TSHR-Gαs signaling integrity. • Constitutive activity studies: comparison of basal versus TSH-stimulated signaling, particularly relevant for constitutively active TSHR mutants associated with thyroid disease. • Multiple myeloma context studies: where TSHR has been reported with non-thyroid functions in MOLP-8, characterization of TSHR signaling and downstream effects in this hematological malignancy background. • Disease mutation modeling: rescue with constitutively active (e.g., D633Y) or inactivating mutant TSHR for hyperthyroidism and hypothyroidism research. EDITGENE recommends this model for researchers investigating TSHR signaling, thyroid disease modeling, and non-canonical TSHR functions in hematological contexts.

Yes. TSHR rescue experiments are well-established as a GPCR rescue system: • Construct design: use a codon-modified TSHR sequence with a C-terminal tag (FLAG, HA). TSHR is a seven-transmembrane GPCR — N-terminal tags after the signal peptide are tolerated, but the large extracellular ligand-binding domain (residues 1-415) must be preserved. • Disease mutation rescue: activating mutations (constitutively active TSHR like D633Y) and inactivating mutations can be introduced to model hyperthyroidism and hypothyroidism in the controlled cellular background. • Functional readout: rescue should restore TSH-stimulated cAMP production (measured by cAMP reporter assays or biochemical cAMP quantification). • MOLP-8 context: in the multiple myeloma background, rescue should additionally consider the non-canonical TSHR functions that have been reported in this cellular context. MOLP-8 is a suspension multiple myeloma cell line — transduction typically uses spinoculation-enhanced lentiviral delivery; expect lower transduction efficiency than adherent lines.